Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 1/20 | 0.55 |
| ▸ | ARG2 | P78540 | 1/20 | 0.55 |
| ▸ | NOS2 | P35228 | 3/20 | 0.48 |
| ▸ | NOS1 | P29475 | 2/20 | 0.48 |
| ▸ | NOS3 | P29474 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | GSR | P00390 | 2/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.41 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.41 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM6 | O15303 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL995282 | 1.00 | ARG1 (0.55) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL36933 | 0.92 | ARG1 (0.61) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL36935 | 0.92 | ARG1 (0.61) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL36934 | 0.92 | ARG1 (0.61) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL29393779 | 0.92 | ARG1 (0.61) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL29378137 | 0.92 | ARG1 (0.61) | ARG1ARG2NOS2NOS1NOS3 | |
| Hydrogen Sulfide SCHEMBL5666458 | 0.90 | ARG1 (0.59) | ARG1ARG2NOS2NOS1NOS3 | |
| Selenium SCHEMBL29993624 | 0.90 | ARG1 (0.59) | ARG1ARG2NOS2NOS1NOS3 | |
| Alanine SCHEMBL9937853 | 0.83 | ARG1 (0.53) | ARG1ARG2NOS2NOS1NOS3 | |
| Alanine SCHEMBL9937848 | 0.83 | ARG1 (0.53) | ARG1ARG2NOS2NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110014226-A1 | HIGH THROUGHPUT PROTEIN INTERACTION ASSAY | MERCK SHARP & DOHME CORP. | 2011-01-20 | — | — | US | disclosed |
| US-20090047303-A1 | Method for improving the immunogenicity of plasmodium antigens | MERCK SHARP & DOHME CORP. | 2009-02-19 | — | — | US | disclosed |
| EP-1603590-A4 | INFLUENZA VIRUS VACCINE | MERCK & CO INC (US) | 2008-08-27 | — | — | EP | disclosed |
| EP-1885395-A2 | A METHOD FOR IMPROVING THE IMMUNOGENICITY OF PLASMODIUM ANTIGENS | Merck & Co., Inc. (US) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006124712-A2 | A METHOD FOR IMPROVING THE IMMUNOGENICITY OF PLASMODIUM ANTIGENS | MERCK & CO., INC. (US) | 2006-11-23 | — | — | WO | disclosed |
| EP-1603590-A2 | INFLUENZA VIRUS VACCINE | Merck & Co. Inc. (US) | 2005-12-14 | — | — | EP | disclosed |
| WO-2004080403-A2 | INFLUENZA VIRUS VACCINE | MERCK & CO. INC. (US) | 2004-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110014226-A1 | HIGH THROUGHPUT PROTEIN INTERACTION ASSAY | SSB, AIP, LY96 | ARG1 3515/4885ARG2 3736/4885NOS2 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.